CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to personalize immunosuppressive therapy for organ transplant patients by utilizing biomarkers to tailor treatment. By identifying patients' immunological responses, the project seeks to improve transplant outcomes and reduce the adverse effects of long-term medication.
Organ transplantation has emerged as the “gold standard” therapy for end-stage organ failure.
Incomplete control of chronic allograft injury but also the adverse effects of long-term immunosuppression (IS) continue to challenge the long-term success of transplantation.
The paradigm is shifting from increasing “net”-IS by novel drugs to the concept of minimizing long-term IS as early as possible.
However, data were almost completely generated by “trial-and-error” observational studies.
It suggest…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
France, Nantes
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Oxford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Barcelona
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
